Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Delta Dunia Makmur Tbk. (DOID) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Delta Dunia Makmur Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Delta Dunia Makmur Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Delta Dunia Makmur Tbk. trades at Rp210 (market cap 1.56T, 3.22M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Delta Dunia Makmur Tbk. is far larger — about 2.7× UBC Medical Indonesia Tbk.'s market cap, and Delta Dunia Makmur Tbk. is more actively traded (3.22M versus 817.3K). Which is the better fit depends on your goals.

DOIDLABS
Market Cap
1.56T584.6B
Volume
3.22M817.3K
Lot
32.16K8.17K
Turnover
673.64M120.01M
Average Price
209.46146.84
Value
673.64M120.01M
Indicative Equilibrium Price
210146
Indicative Equilibrium Volume
59759

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DOID
View details
LABS
View details

About Delta Dunia Makmur Tbk.

PT Delta Dunia Makmur Tbk formerly PT. Daeyu Orchid Indonesia, Tbk (the Company) was established on November 26, 1990 under the name PT. Daeyu Poleko Indonesia as a foreign investment and changed the investment status to be local investment on May 14, 1998.

Read more on DOID

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS